DrugPatentWatch Database Preview

AUSTEDO Drug Profile

« Back to Dashboard

When do Austedo patents expire, and when can generic versions of Austedo launch?

Austedo is a drug marketed by Teva Branded Pharm and is included in one NDA. There are five patents protecting this drug.

This drug has twenty-nine patent family members in eleven countries.

The generic ingredient in AUSTEDO is deutetrabenazine. One supplier is listed for this compound. Additional details are available on the deutetrabenazine profile page.

Summary for AUSTEDO

International Patents:	29
US Patents:	5
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	11
Patent Applications:	6
Drug Prices:	Drug price information for AUSTEDO
DailyMed Link:	AUSTEDO at DailyMed

Generic Entry Opportunity Date for AUSTEDO

NDA:

208082

Dosage:

TABLET;ORAL

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Synonyms for AUSTEDO

(3R,11bR)-3-(2-methylpropyl)-9,10-bis(trideuteriomethoxy)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one

(3RS,11Brs)-9,10-di((2H3)methoxy)-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2H-benzo(a)quinolizin-2-one

[2H6]-(+)-Tetrabenazine|||[2H6]-(+)- 9,10-Dimethoxy-1,3R,4,6,7,11bR-hexahydro-3-isobutyl-2H-benzo[a]quinolizin-2-one

1392826-25-3

2H-Benzo(a)quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-di(methoxy-d3)-3-(2-methylpropyl)-, (3R,11bR)-rel-

CHEMBL3137326

D10701

DB12161

Deutetrabenazine

Deutetrabenazine (USAN/INN)

Deutetrabenazine [USAN:INN]

Dutetrabenazine

GTPL8707

HY-B0590S

Ro 1-9569 D6

SCHEMBL13321841

SCHEMBL16227993

SCHEMBL16228022

SD 809

SD-809

SD809

Tetrabenazine D6

UNII-P341G6W9NB component MKJIEFSOBYUXJB-VFJJUKLQSA-N

UNII-P341G6W9NB component MKJIEFSOBYUXJB-WEZHFFAMSA-N

US Patents and Regulatory Information for AUSTEDO

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva Branded Pharm	AUSTEDO	deutetrabenazine	TABLET;ORAL	208082-001	Apr 3, 2017		RX	Yes	No			Y	Y
Teva Branded Pharm	AUSTEDO	deutetrabenazine	TABLET;ORAL	208082-002	Apr 3, 2017		RX	Yes	No
Teva Branded Pharm	AUSTEDO	deutetrabenazine	TABLET;ORAL	208082-003	Apr 3, 2017		RX	Yes	Yes			Y
Teva Branded Pharm	AUSTEDO	deutetrabenazine	TABLET;ORAL	208082-001	Apr 3, 2017		RX	Yes	No
Teva Branded Pharm	AUSTEDO	deutetrabenazine	TABLET;ORAL	208082-001	Apr 3, 2017		RX	Yes	No			Y

International Patents for AUSTEDO

Country	Document Number	Estimated Expiration
Spain	2563820
European Patent Office	2897615
World Intellectual Property Organization (WIPO)	2010044981
European Patent Office	3061760
Japan	5616345